SummaryRMgm-4886
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene mutation |
Reference (PubMed-PMID number) | Not published (yet) |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | RMgm-4885 |
Other information parent line | In this mutant the akarin gene has been deleted. This mutant does not contain a drug selectable marker (SM). The SM has been removed by negative selection |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Kehrer J, Frischknecht F |
Name Group/Department | Center for Infectious Diseases, Integrative Parasitology |
Name Institute | Heidelberg University Medical School |
City | Heidelberg |
Country | Germany |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4886 |
Principal name | akratinEYKY/AAAA |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not tested |
Gametocyte/Gamete | Slightly reduced exflagellation |
Fertilization and ookinete | Not different from wild type |
Oocyst | Absence of oocyst formation |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Phenotype The Akratin-EYKK/AAAA-GFP mutant showed similar staining patterns in asexual and sexual parasite stages compared with akratin-GFP. (see mutant RMgm-4888) However, in contrast to the mostly peripheral and vesicular localization of akratin-GFP in ookinetes the akratin-EYKK/AAAA GFP signal was diffusely localized within the cytoplasm Other mutants |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1105300 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0505700 | ||||||||||||||||||||||||||
Gene product | conserved Plasmodium membrane protein, unknown function | ||||||||||||||||||||||||||
Gene product: Alternative name | akratin | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Short description of the mutation | C-terminal EYKK motif changed into four alanines and GFP tag | ||||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||||
Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | unknown | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | The 5`UTR together with the entire ORF of PbANKA_1105300 was amplified from wt gDNA using primers JK66 and JK152 and inserted into the pL28 plasmid using KpnI and NdeI leading to the replacement of the selection marker. A TgDHFR selection cassette was amplified using primers JK153 and JK154 and inserted between the GFP and 3`UTR using NotI and EcorV resulting in plasmid 361 pL59. The 5`UTR together with the entire ORF was amplified from wt gDNA using primers JK66 and a reverse Primer introducing the mutations and inserted into the pL59 plasmid using KpnI and NdeI resulting in pL84. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |